Literature DB >> 23354808

Patient perspectives on type 2 diabetes and medicine use during Ramadan among Pakistanis in Denmark.

Anna Mygind1, Maria Kristiansen, Inge Wittrup, Lotte Stig Nørgaard.   

Abstract

BACKGROUND: Type 2 diabetes is highly prevalent among people of Pakistani background. Studies show that adherence to medicines is complicated for people with type 2 diabetes in general. Also, studies indicate that many people with type 2 diabetes and Muslim background fast during the month of Ramadan without adequate counselling on how to adjust their medicines.
OBJECTIVE: To explore patient perspectives on medicine use during Ramadan, reasons for fasting and experiences with counselling on medicine use during Ramadan among people of Pakistani background with type 2 diabetes and at least one other chronic condition.
SETTING: Greater Copenhagen, Denmark.
METHOD: The analysis is based on a study exploring lived experiences with counselling on medicines using semi-structured interviews and medication reviews. The analysis presented here builds on the subset of patients with Pakistani background (six interviewers).
RESULTS: All interviewees pointed out that Islam allows ill people to refrain from fasting during Ramadan. However, all had fasted during Ramadan despite being diagnosed with type 2 diabetes. While fasting, they adapted their use of medicines in different ways, e.g. by changing the time of intake or by skipping morning medicines. Fasting during Ramadan meant a feeling of improvement in well-being for all interviewees. Reasons for this improvement included physiological, social and religious aspects. Healthcare professionals were rarely included in the decision-making process on whether or not to fast. Instead, friends and relatives, especially those with type 2 diabetes, were considered important to the decision-making process.
CONCLUSION: For people with Muslim background and a chronic condition, fasting during Ramadan may mean changes in medicine use that are not always discussed with healthcare professionals. Healthcare professionals should acknowledge that Muslim patients may find fasting during Ramadan beneficial to their well-being and therefore choose to fast despite the Islamic rule of exemption. This patient-centred approach to counselling on medicines may facilitate better medicine use and thus better clinical health outcomes among patients that choose to fast.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354808     DOI: 10.1007/s11096-012-9716-1

Source DB:  PubMed          Journal:  Int J Clin Pharm


  16 in total

Review 1.  Ramadan fasting and diabetes.

Authors:  Aziz Sheikh; Sunita Wallia
Journal:  BMJ       Date:  2007-09-22

2.  Declaration of Helsinki. Ethical principles for medical research involving human subjects.

Authors: 
Journal:  J Indian Med Assoc       Date:  2009-06

Review 3.  Prevalence, risk factors and complications associated with type 2 diabetes in migrant South Asians.

Authors:  Sara D Garduño-Diaz; Santosh Khokhar
Journal:  Diabetes Metab Res Rev       Date:  2012-01       Impact factor: 4.876

4.  Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma--interviewing patients at home.

Authors:  Lotte Stig Haugbølle; Ellen Westh Sørensen
Journal:  Pharm World Sci       Date:  2006-10-26

5.  Health is a spiritual thing: perspectives of health care professionals and female Somali and Bangladeshi women on the health impacts of fasting during Ramadan.

Authors:  Rubini Pathy; Kelsey E Mills; Sharon Gazeley; Andrea Ridgley; Tara Kiran
Journal:  Ethn Health       Date:  2011-02       Impact factor: 2.772

6.  Ramadan fasting with diabetes: an interview study of inpatients' and general practitioners' attitudes in the South of France.

Authors:  B Gaborit; O Dutour; O Ronsin; C Atlan; P Darmon; R Gharsalli; V Pradel; F Dadoun; A Dutour
Journal:  Diabetes Metab       Date:  2011-04-08       Impact factor: 6.041

7.  A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study.

Authors:  Ibrahim Salti; Eric Bénard; Bruno Detournay; Monique Bianchi-Biscay; Corinne Le Brigand; Céline Voinet; Abdul Jabbar
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

8.  Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education.

Authors:  M Y Ahmedani; M S Haque; A Basit; A Fawwad; S F D Alvi
Journal:  Diabet Med       Date:  2012-06       Impact factor: 4.359

9.  Diabetes: a cross-cultural interview study of immigrants from Somalia.

Authors:  Anne-Marie Wallin; Monica Löfvander; Gerd Ahlström
Journal:  J Clin Nurs       Date:  2007-11       Impact factor: 3.036

10.  Recommendations for management of diabetes during Ramadan: update 2010.

Authors:  Monira Al-Arouj; Samir Assaad-Khalil; John Buse; Ibtihal Fahdil; Mohamed Fahmy; Sherif Hafez; Mohamed Hassanein; Mahmoud Ashraf Ibrahim; David Kendall; Suhail Kishawi; Abdulrazzaq Al-Madani; Abdullah Ben Nakhi; Khaled Tayeb; Abraham Thomas
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 17.152

View more
  17 in total

1.  Utilisation of Healthcare Services and Medicines by Pakistani Migrants Residing in High Income Countries: A Systematic Review and Thematic Synthesis.

Authors:  Ahsan Saleem; Kathryn J Steadman; Jasmina Fejzic
Journal:  J Immigr Minor Health       Date:  2019-10

2.  Community pharmacists' knowledge of diabetes management during Ramadan in Egypt.

Authors:  Mohamed E K Amin; Betty Chewning
Journal:  Int J Clin Pharm       Date:  2014-09-25

3.  Communicating with Clinicians on Fasting during Ramadan: The Patients' Perspective.

Authors:  Mohamed Ezzat Khamis Amin; Ahmed Abdelmageed; Marwa J Farhat
Journal:  J Relig Health       Date:  2021-04

4.  Cultural barriers encountered by Norwegian community pharmacists in providing service to non-Western immigrant patients.

Authors:  Helle Håkonsen; Karine Lees; Else-Lydia Toverud
Journal:  Int J Clin Pharm       Date:  2014-09-04

5.  Comprehensive care for patients with diabetes in Ramadan: A module for pharmacy students and pharmacists.

Authors:  Lina Abdallah Al Rifai; Lama Soubra; Mohamed Hassanein; Mohamed Ezzat Khamis Amin
Journal:  Saudi Pharm J       Date:  2022-02-14       Impact factor: 4.562

Review 6.  Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients.

Authors:  Kamran Ma Aziz
Journal:  Diabetes Metab Syndr Obes       Date:  2015-04-16       Impact factor: 3.168

7.  Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study.

Authors:  Serge Halimi; Marc Levy; Dominique Huet; Stéphane Quéré; Sylvie Dejager
Journal:  Diabetes Ther       Date:  2013-08-31       Impact factor: 2.945

Review 8.  Patients' management of type 2 diabetes in Middle Eastern countries: review of studies.

Authors:  Zahra Khalil Alsairafi; Kevin Michael Geoffrey Taylor; Felicity J Smith; Abdulnabi T Alattar
Journal:  Patient Prefer Adherence       Date:  2016-06-10       Impact factor: 2.711

9.  Fasting with diabetes: a prospective observational study.

Authors:  Muhammad Jawad Noon; Haseeb Ahmad Khawaja; Osama Ishtiaq; Quratulain Khawaja; Sana Minhas; Asfandyar Khan Niazi; Abdul Mannan Khan Minhas; Umar Rasool Malhi
Journal:  BMJ Glob Health       Date:  2016-09-08

10.  Diabetes education and medication adjustment in Ramadan (DEAR) program prepares for self-management during fasting with tele-health support from pre-Ramadan to post-Ramadan.

Authors:  Sueziani B Zainudin; Khalishah Nadhirah B Abu Bakar; Salmiah B Abdullah; Aslena B Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2018-06-12       Impact factor: 3.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.